A Phase 3 Trial of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis
- Author
- KING, Talmadge E1 ; BRADFORD, Williamson Z2 ; LEDERER, David J9 ; NATHAN, Steven D10 ; PEREIRA, Carlos A11 ; SAHN, Steven A12 ; SUSSMAN, Robert13 ; SWIGRIS, Jeffrey J14 ; NOBLE, Paul W3 ; CASTRO-BERNARDINI, Socorro4 ; FAGAN, Elizabeth A2 ; GLASPOLE, Ian5 ; GLASSBERG, Marilyn K7 ; GORINA, Eduard2 ; HOPKINS, Peter M6 ; KARDATZKE, David2 ; LANCASTER, Lisa8
[1] University of California, San Francisco, San Francisco, United States
[2] InterMune, Brisbane, Australia
[3] Cedars-Sinai Medical Center, Los Angeles, California, United States
[4] Neumocare, Clínica San Borja, Lima, Peru
[5] Alfred Hospital, Melbourne, VIC, Australia
[6] Prince Charles Hospital, Brisbane, QLD, Australia
[7] University of Miami Miller School of Medicine, Miami, United States
[8] Vanderbilt University Medical Center, Nashville, United States
[9] Columbia University Medical Center, New York, United States
[10] Inova Fairfax Hospital, Falls Church, VA, United States
[11] Paulista School of Medicine, Federal University of São Paulo, São Paulo, Brazil
[12] Medical University of South Carolina, Charleston, United States
[13] Atlantic Health System-Overlook Medical Center, Summit, NJ, United States
[14] National Jewish Health, Denver, United States
ASCEND Study Group - Source
The New England journal of medicine. 2014, Vol 370, Num 22, pp 2083-2092, 10 p ; ref : 27 ref
- CODEN
- NEJMAG
- ISSN
- 0028-4793
- Scientific domain
- General medicine general surgery
- Publisher
- Massachusetts Medical Society, Waltham, MA
- Publication country
- United States
- Document type
- Article
- Language
- English
- Keyword (fr)
- Fibrose des poumons Homme Idiopathique Immunodépresseur Médecine Pirfénidone Pathologie de l'appareil respiratoire Pathologie des poumons
- Keyword (en)
- Pulmonary fibrosis Human Idiopathic Immunosuppressive agent Medicine Pirfenidone Respiratory disease Lung disease
- Keyword (es)
- Fibrosis pulmonar Hombre Idiopático Inmunodepresor Medicina Pirfenidona Aparato respiratorio patología Pulmón patología
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B11 Pneumology / 002B11D Respiratory system : syndromes and miscellaneous diseases
- Discipline
- Generalities in medical sciences Pulmonology
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 28546920
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Access to the document
Install on your browser
DOI
10.1056/NEJMoa1402582 
https://dx.doi.org/10.1056/NEJMoa1402582
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:21:\"10.1056\/NEJMoa1402582\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:77:\"A Phase 3 Trial of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis\";s:9:\"\u0000*\u0000jtitle\";s:35:\"The New England journal of medicine\";s:9:\"\u0000*\u0000stitle\";s:15:\"N. Engl. j. med\";s:7:\"\u0000*\u0000date\";s:4:\"2014\";s:9:\"\u0000*\u0000volume\";s:3:\"370\";s:8:\"\u0000*\u0000issue\";s:2:\"22\";s:8:\"\u0000*\u0000spage\";s:4:\"2083\";s:8:\"\u0000*\u0000epage\";s:4:\"2092\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0028-4793\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:4:\"KING\";s:10:\"\u0000*\u0000aufirst\";s:10:\"Talmadge E\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:16:{i:0;s:22:\"BRADFORD, Williamson Z\";i:1;s:16:\"LEDERER, David J\";i:2;s:16:\"NATHAN, Steven D\";i:3;s:17:\"PEREIRA, Carlos A\";i:4;s:14:\"SAHN, Steven A\";i:5;s:15:\"SUSSMAN, Robert\";i:6;s:18:\"SWIGRIS, Jeffrey J\";i:7;s:13:\"NOBLE, Paul W\";i:8;s:26:\"CASTRO-BERNARDINI, Socorro\";i:9;s:18:\"FAGAN, Elizabeth A\";i:10;s:13:\"GLASPOLE, Ian\";i:11;s:20:\"GLASSBERG, Marilyn K\";i:12;s:14:\"GORINA, Eduard\";i:13;s:16:\"HOPKINS, Peter M\";i:14;s:16:\"KARDATZKE, David\";i:15;s:15:\"LANCASTER, Lisa\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"NEJMAG\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:77:\"A Phase 3 Trial of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis\";s:8:\"\u0000*\u0000place\";s:11:\"Waltham, MA\";s:6:\"\u0000*\u0000pub\";s:29:\"Massachusetts Medical Society\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"10\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:21:\"10.1056\/NEJMoa1402582\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:77:\"A Phase 3 Trial of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis\";s:9:\"\u0000*\u0000jtitle\";s:35:\"The New England journal of medicine\";s:9:\"\u0000*\u0000stitle\";s:15:\"N. Engl. j. med\";s:7:\"\u0000*\u0000date\";s:4:\"2014\";s:9:\"\u0000*\u0000volume\";s:3:\"370\";s:8:\"\u0000*\u0000issue\";s:2:\"22\";s:8:\"\u0000*\u0000spage\";s:4:\"2083\";s:8:\"\u0000*\u0000epage\";s:4:\"2092\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0028-4793\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:4:\"KING\";s:10:\"\u0000*\u0000aufirst\";s:10:\"Talmadge E\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:16:{i:0;s:22:\"BRADFORD, Williamson Z\";i:1;s:16:\"LEDERER, David J\";i:2;s:16:\"NATHAN, Steven D\";i:3;s:17:\"PEREIRA, Carlos A\";i:4;s:14:\"SAHN, Steven A\";i:5;s:15:\"SUSSMAN, Robert\";i:6;s:18:\"SWIGRIS, Jeffrey J\";i:7;s:13:\"NOBLE, Paul W\";i:8;s:26:\"CASTRO-BERNARDINI, Socorro\";i:9;s:18:\"FAGAN, Elizabeth A\";i:10;s:13:\"GLASPOLE, Ian\";i:11;s:20:\"GLASSBERG, Marilyn K\";i:12;s:14:\"GORINA, Eduard\";i:13;s:16:\"HOPKINS, Peter M\";i:14;s:16:\"KARDATZKE, David\";i:15;s:15:\"LANCASTER, Lisa\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"NEJMAG\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:77:\"A Phase 3 Trial of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis\";s:8:\"\u0000*\u0000place\";s:11:\"Waltham, MA\";s:6:\"\u0000*\u0000pub\";s:29:\"Massachusetts Medical Society\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"10\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:21:\"10.1056\/NEJMoa1402582\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Unpaywall access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:21:\"10.1056\/NEJMoa1402582\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:77:\"A Phase 3 Trial of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis\";s:9:\"\u0000*\u0000jtitle\";s:35:\"The New England journal of medicine\";s:9:\"\u0000*\u0000stitle\";s:15:\"N. Engl. j. med\";s:7:\"\u0000*\u0000date\";s:4:\"2014\";s:9:\"\u0000*\u0000volume\";s:3:\"370\";s:8:\"\u0000*\u0000issue\";s:2:\"22\";s:8:\"\u0000*\u0000spage\";s:4:\"2083\";s:8:\"\u0000*\u0000epage\";s:4:\"2092\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0028-4793\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:4:\"KING\";s:10:\"\u0000*\u0000aufirst\";s:10:\"Talmadge E\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:16:{i:0;s:22:\"BRADFORD, Williamson Z\";i:1;s:16:\"LEDERER, David J\";i:2;s:16:\"NATHAN, Steven D\";i:3;s:17:\"PEREIRA, Carlos A\";i:4;s:14:\"SAHN, Steven A\";i:5;s:15:\"SUSSMAN, Robert\";i:6;s:18:\"SWIGRIS, Jeffrey J\";i:7;s:13:\"NOBLE, Paul W\";i:8;s:26:\"CASTRO-BERNARDINI, Socorro\";i:9;s:18:\"FAGAN, Elizabeth A\";i:10;s:13:\"GLASPOLE, Ian\";i:11;s:20:\"GLASSBERG, Marilyn K\";i:12;s:14:\"GORINA, Eduard\";i:13;s:16:\"HOPKINS, Peter M\";i:14;s:16:\"KARDATZKE, David\";i:15;s:15:\"LANCASTER, Lisa\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"NEJMAG\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:77:\"A Phase 3 Trial of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis\";s:8:\"\u0000*\u0000place\";s:11:\"Waltham, MA\";s:6:\"\u0000*\u0000pub\";s:29:\"Massachusetts Medical Society\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"10\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:21:\"10.1056\/NEJMoa1402582\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:77:\"A Phase 3 Trial of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis\";s:9:\"\u0000*\u0000jtitle\";s:35:\"The New England journal of medicine\";s:9:\"\u0000*\u0000stitle\";s:15:\"N. Engl. j. med\";s:7:\"\u0000*\u0000date\";s:4:\"2014\";s:9:\"\u0000*\u0000volume\";s:3:\"370\";s:8:\"\u0000*\u0000issue\";s:2:\"22\";s:8:\"\u0000*\u0000spage\";s:4:\"2083\";s:8:\"\u0000*\u0000epage\";s:4:\"2092\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0028-4793\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:4:\"KING\";s:10:\"\u0000*\u0000aufirst\";s:10:\"Talmadge E\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:16:{i:0;s:22:\"BRADFORD, Williamson Z\";i:1;s:16:\"LEDERER, David J\";i:2;s:16:\"NATHAN, Steven D\";i:3;s:17:\"PEREIRA, Carlos A\";i:4;s:14:\"SAHN, Steven A\";i:5;s:15:\"SUSSMAN, Robert\";i:6;s:18:\"SWIGRIS, Jeffrey J\";i:7;s:13:\"NOBLE, Paul W\";i:8;s:26:\"CASTRO-BERNARDINI, Socorro\";i:9;s:18:\"FAGAN, Elizabeth A\";i:10;s:13:\"GLASPOLE, Ian\";i:11;s:20:\"GLASSBERG, Marilyn K\";i:12;s:14:\"GORINA, Eduard\";i:13;s:16:\"HOPKINS, Peter M\";i:14;s:16:\"KARDATZKE, David\";i:15;s:15:\"LANCASTER, Lisa\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"NEJMAG\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:77:\"A Phase 3 Trial of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis\";s:8:\"\u0000*\u0000place\";s:11:\"Waltham, MA\";s:6:\"\u0000*\u0000pub\";s:29:\"Massachusetts Medical Society\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"10\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:21:\"10.1056\/NEJMoa1402582\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:77:\"A Phase 3 Trial of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis\";s:9:\"\u0000*\u0000jtitle\";s:35:\"The New England journal of medicine\";s:9:\"\u0000*\u0000stitle\";s:15:\"N. Engl. j. med\";s:7:\"\u0000*\u0000date\";s:4:\"2014\";s:9:\"\u0000*\u0000volume\";s:3:\"370\";s:8:\"\u0000*\u0000issue\";s:2:\"22\";s:8:\"\u0000*\u0000spage\";s:4:\"2083\";s:8:\"\u0000*\u0000epage\";s:4:\"2092\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0028-4793\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:4:\"KING\";s:10:\"\u0000*\u0000aufirst\";s:10:\"Talmadge E\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:16:{i:0;s:22:\"BRADFORD, Williamson Z\";i:1;s:16:\"LEDERER, David J\";i:2;s:16:\"NATHAN, Steven D\";i:3;s:17:\"PEREIRA, Carlos A\";i:4;s:14:\"SAHN, Steven A\";i:5;s:15:\"SUSSMAN, Robert\";i:6;s:18:\"SWIGRIS, Jeffrey J\";i:7;s:13:\"NOBLE, Paul W\";i:8;s:26:\"CASTRO-BERNARDINI, Socorro\";i:9;s:18:\"FAGAN, Elizabeth A\";i:10;s:13:\"GLASPOLE, Ian\";i:11;s:20:\"GLASSBERG, Marilyn K\";i:12;s:14:\"GORINA, Eduard\";i:13;s:16:\"HOPKINS, Peter M\";i:14;s:16:\"KARDATZKE, David\";i:15;s:15:\"LANCASTER, Lisa\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"NEJMAG\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:77:\"A Phase 3 Trial of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis\";s:8:\"\u0000*\u0000place\";s:11:\"Waltham, MA\";s:6:\"\u0000*\u0000pub\";s:29:\"Massachusetts Medical Society\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"10\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
